The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma

Overview of attention for article published in Frontiers in Pharmacology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 884 followers.

@BertrandBio Actually, VERU-111 / sabizabulin is an optimized less toxic colchicine like molecule https://t.co/FNsnp7hUdI

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.